(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Greenwich LifeSciences, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, April 25th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,570,602 | P-Purchase | A | 3,600 | 9.88 USD | 35,568 USD |
| Thursday, April 17th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,567,002 | P-Purchase | A | 5,400 | 8.98 USD | 48,492 USD |
| Monday, April 7th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,561,602 | P-Purchase | A | 3,600 | 9.10 USD | 32,760 USD |
| Friday, April 4th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,558,002 | P-Purchase | A | 5,500 | 8.73 USD | 48,015 USD |
| Friday, January 10th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,552,502 | P-Purchase | A | 2,500 | 12.51 USD | 31,275 USD |
| Tuesday, January 7th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,550,002 | P-Purchase | A | 1,800 | 13.75 USD | 24,750 USD |
| Monday, January 6th, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,548,202 | P-Purchase | A | 1,100 | 13.31 USD | 14,641 USD |
| Friday, January 3rd, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,547,102 | P-Purchase | A | 3,400 | 12.95 USD | 44,030 USD |
| Thursday, January 2nd, 2025 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,543,702 | P-Purchase | A | 2,000 | 11.97 USD | 23,940 USD |
| Tuesday, December 31st, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,541,702 | P-Purchase | A | 2,400 | 11.36 USD | 27,264 USD |
| Monday, December 30th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,539,302 | P-Purchase | A | 3,200 | 11.12 USD | 35,584 USD |
| Tuesday, December 24th, 2024 | Daugherty Frank Joseph | director, officer: Chief Medical Officer | 209,780 | A-Award | A | 104,890 | 12.16 USD | 1,275,462 USD |
| Tuesday, December 24th, 2024 | Hallock Kenneth | director | 82,698 | A-Award | A | 41,349 | 12.16 USD | 502,804 USD |
| Tuesday, December 24th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2,247,462 | A-Award | A | 25,008 | 12.16 USD | 304,097 USD |
| Tuesday, December 24th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2,222,454 | A-Award | A | 1,148,723 | 12.16 USD | 13,968,472 USD |
| Tuesday, December 24th, 2024 | Rothe Eric | director | 82,698 | A-Award | A | 41,349 | 12.16 USD | 502,804 USD |
| Tuesday, December 24th, 2024 | Thompson Jaye | officer: VP Clinical Reg Affairs | 299,636 | A-Award | A | 149,818 | 12.16 USD | 1,821,787 USD |
| Tuesday, December 24th, 2024 | McWilliams David | director | 123,968 | A-Award | A | 61,984 | 12.16 USD | 753,725 USD |
| Thursday, November 21st, 2024 | Thompson Jaye | officer: VP Clinical Reg Affairs | 264,148 | P-Purchase | A | 1,000 | 12.91 USD | 12,910 USD |
| Thursday, September 26th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,536,102 | P-Purchase | A | 1,500 | 14.63 USD | 21,945 USD |
| Monday, August 12th, 2024 | Thompson Jaye | officer: VP Clinical Reg Affairs | 263,148 | P-Purchase | A | 800 | 13.85 USD | 11,080 USD |
| Tuesday, August 6th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,534,602 | P-Purchase | A | 2,000 | 13.81 USD | 27,620 USD |
| Monday, August 5th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,532,602 | P-Purchase | A | 5,500 | 13.18 USD | 72,490 USD |
| Friday, August 2nd, 2024 | Thompson Jaye | officer: VP Clinical Reg Affairs | 262,348 | P-Purchase | A | 1,000 | 15.15 USD | 15,150 USD |
| Tuesday, July 23rd, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,527,102 | P-Purchase | A | 1,500 | 15.89 USD | 23,835 USD |
| Thursday, July 18th, 2024 | Thompson Jaye | officer: VP Clinical Reg Affairs | 261,348 | P-Purchase | A | 1,000 | 16.00 USD | 16,000 USD |
| Thursday, June 13th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,525,602 | P-Purchase | A | 174,825 | 14.30 USD | 2,499,998 USD |
| Monday, April 1st, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,350,777 | P-Purchase | A | 3,000 | 19.08 USD | 57,240 USD |
| Friday, March 22nd, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,347,777 | P-Purchase | A | 2,500 | 19.98 USD | 49,950 USD |
| Wednesday, March 20th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,345,277 | P-Purchase | A | 1,500 | 17.68 USD | 26,520 USD |
| Tuesday, March 5th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,343,777 | P-Purchase | A | 30,500 | 12.49 USD | 380,945 USD |
| Monday, March 4th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,340,277 | P-Purchase | A | 4,100 | 13.03 USD | 53,423 USD |
| Friday, February 16th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,336,177 | P-Purchase | A | 10,800 | 11.16 USD | 120,528 USD |
| Thursday, February 15th, 2024 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,325,377 | P-Purchase | A | 12,700 | 11.07 USD | 140,589 USD |
| Friday, November 10th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,312,677 | P-Purchase | A | 5,000 | 10.17 USD | 50,838 USD |
| Friday, November 3rd, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,307,677 | P-Purchase | A | 3,500 | 9.11 USD | 31,885 USD |
| Friday, October 27th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 260,348 | P-Purchase | A | 500 | 8.57 USD | 4,285 USD |
| Thursday, October 26th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,304,177 | P-Purchase | A | 2,500 | 7.97 USD | 19,925 USD |
| Wednesday, October 25th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,301,677 | P-Purchase | A | 2,500 | 7.91 USD | 19,775 USD |
| Tuesday, October 10th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,299,177 | P-Purchase | A | 1,000 | 9.07 USD | 9,070 USD |
| Wednesday, October 4th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,298,177 | P-Purchase | A | 2,000 | 8.63 USD | 17,260 USD |
| Tuesday, September 26th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 259,848 | P-Purchase | A | 600 | 8.71 USD | 5,226 USD |
| Tuesday, September 19th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,296,177 | P-Purchase | A | 4,000 | 8.95 USD | 35,800 USD |
| Monday, September 11th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,292,177 | P-Purchase | A | 1,000 | 9.48 USD | 9,480 USD |
| Tuesday, August 22nd, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,291,177 | P-Purchase | A | 1,000 | 9.97 USD | 9,970 USD |
| Friday, August 4th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,290,177 | P-Purchase | A | 2,000 | 10.55 USD | 21,100 USD |
| Friday, July 21st, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,288,177 | P-Purchase | A | 1,000 | 9.20 USD | 9,200 USD |
| Thursday, July 13th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 259,248 | P-Purchase | A | 250 | 9.49 USD | 2,373 USD |
| Wednesday, May 17th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,287,177 | P-Purchase | A | 1,000 | 11.69 USD | 11,690 USD |
| Friday, April 28th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 258,998 | P-Purchase | A | 250 | 11.22 USD | 2,805 USD |
| Wednesday, April 19th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,286,177 | P-Purchase | A | 7,000 | 11.10 USD | 77,700 USD |
| Tuesday, April 18th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,279,177 | P-Purchase | A | 2,000 | 11.12 USD | 22,240 USD |
| Tuesday, April 11th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 258,745 | P-Purchase | A | 1,000 | 11.87 USD | 11,870 USD |
| Tuesday, April 11th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 5,271,177 | P-Purchase | A | 5,000 | 12.42 USD | 62,100 USD |
| Wednesday, March 15th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 257,745 | P-Purchase | A | 250 | 12.71 USD | 3,178 USD |
| Friday, March 10th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2,737,486 | P-Purchase | A | 1,000 | 12.12 USD | 12,120 USD |
| Friday, February 24th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 257,495 | P-Purchase | A | 250 | 15.40 USD | 3,849 USD |
| Friday, February 17th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2,736,486 | P-Purchase | A | 600 | 16.53 USD | 9,918 USD |
| Friday, February 10th, 2023 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2,735,886 | P-Purchase | A | 1,000 | 18.68 USD | 18,680 USD |
| Friday, February 3rd, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 257,245 | P-Purchase | A | 250 | 20.84 USD | 5,210 USD |
| Friday, January 27th, 2023 | Patel Snehal | officer: CEO and CFO | 2,734,886 | P-Purchase | A | 2,000 | 19.35 USD | 38,700 USD |
| Friday, January 27th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 256,995 | P-Purchase | A | 250 | 19.20 USD | 4,800 USD |
| Friday, January 20th, 2023 | Patel Snehal | officer: CEO and CFO | 2,732,886 | P-Purchase | A | 1,500 | 17.37 USD | 26,055 USD |
| Friday, January 13th, 2023 | Thompson Jaye | officer: VP Clinical Reg Affairs | 256,745 | P-Purchase | A | 250 | 16.50 USD | 4,125 USD |
| Friday, January 6th, 2023 | Patel Snehal | officer: CEO and CFO | 2,731,386 | P-Purchase | A | 1,500 | 15.18 USD | 22,770 USD |
| Thursday, December 29th, 2022 | Patel Snehal | officer: CEO and CFO | 2,729,886 | P-Purchase | A | 4,000 | 15.19 USD | 60,760 USD |
| Friday, December 16th, 2022 | Patel Snehal | officer: CEO and CFO | 2,725,886 | P-Purchase | A | 1,000 | 13.01 USD | 13,010 USD |
| Friday, December 16th, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 256,495 | P-Purchase | A | 250 | 12.94 USD | 3,235 USD |
| Friday, December 9th, 2022 | Patel Snehal | officer: CEO and CFO | 2,724,886 | P-Purchase | A | 2,000 | 13.11 USD | 26,220 USD |
| Friday, December 2nd, 2022 | Patel Snehal | officer: CEO and CFO | 2,722,886 | P-Purchase | A | 1,000 | 13.84 USD | 13,840 USD |
| Friday, December 2nd, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 256,245 | P-Purchase | A | 250 | 13.98 USD | 3,495 USD |
| Wednesday, November 2nd, 2022 | Patel Snehal | officer: CEO and CFO | 2,721,886 | P-Purchase | A | 2,000 | 8.79 USD | 17,580 USD |
| Friday, October 14th, 2022 | Patel Snehal | officer: CEO and CFO | 2,719,886 | P-Purchase | A | 3,000 | 9.75 USD | 29,250 USD |
| Friday, October 7th, 2022 | Patel Snehal | officer: CEO and CFO | 2,716,886 | P-Purchase | A | 2,000 | 9.72 USD | 19,440 USD |
| Friday, September 30th, 2022 | Patel Snehal | officer: CEO and CFO | 2,714,886 | P-Purchase | A | 1,000 | 9.46 USD | 9,460 USD |
| Thursday, September 29th, 2022 | Patel Snehal | officer: CEO and CFO | 2,713,886 | P-Purchase | A | 1,000 | 9.23 USD | 9,230 USD |
| Friday, June 24th, 2022 | Patel Snehal | officer: CEO and CFO | 2,706,421 | P-Purchase | A | 22,535 | 9.13 USD | 205,745 USD |
| Wednesday, June 22nd, 2022 | Daugherty Frank Joseph | officer: Chief Medical Officer | 104,890 | A-Award | A | 104,890 | 0.00 USD | 0 USD |
| Wednesday, June 22nd, 2022 | Daugherty Frank Joseph | director, officer: Chief Medical Officer | 104,890 | A-Award | A | 104,890 | 7.63 USD | 800,311 USD |
| Wednesday, June 22nd, 2022 | Patel Snehal | officer: CEO and CFO | 1,073,731 | A-Award | A | 25,008 | 0.00 USD | 0 USD |
| Wednesday, June 22nd, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 149,818 | A-Award | A | 149,818 | 0.00 USD | 0 USD |
| Wednesday, June 22nd, 2022 | Hallock Kenneth | director: | 41,349 | A-Award | A | 41,349 | 0.00 USD | 0 USD |
| Wednesday, June 22nd, 2022 | Hallock Kenneth | director | 41,349 | A-Award | A | 41,349 | 7.63 USD | 315,493 USD |
| Wednesday, June 22nd, 2022 | Rothe Eric | director: | 41,349 | A-Award | A | 41,349 | 0.00 USD | 0 USD |
| Wednesday, June 22nd, 2022 | McWilliams David | director: | 61,984 | A-Award | A | 61,984 | 0.00 USD | 0 USD |
| Thursday, June 16th, 2022 | Patel Snehal | officer: CEO and CFO | 2,683,886 | P-Purchase | A | 8,000 | 7.13 USD | 57,040 USD |
| Tuesday, June 14th, 2022 | Patel Snehal | officer: CEO and CFO | 2,675,886 | P-Purchase | A | 12,000 | 7.91 USD | 94,920 USD |
| Friday, June 10th, 2022 | Patel Snehal | officer: CEO and CFO | 2,663,886 | P-Purchase | A | 12,000 | 8.33 USD | 99,960 USD |
| Thursday, June 9th, 2022 | Patel Snehal | officer: CEO and CFO | 1,243,453 | P-Purchase | A | 4,500 | 10.90 USD | 49,050 USD |
| Tuesday, June 7th, 2022 | Patel Snehal | officer: CEO and CFO | 1,238,953 | P-Purchase | A | 6,000 | 8.55 USD | 51,300 USD |
| Friday, June 3rd, 2022 | Patel Snehal | officer: CEO and CFO | 1,232,953 | P-Purchase | A | 9,250 | 8.35 USD | 77,238 USD |
| Thursday, June 2nd, 2022 | Patel Snehal | officer: CEO and CFO | 1,223,703 | P-Purchase | A | 6,774 | 7.38 USD | 49,992 USD |
| Monday, April 25th, 2022 | Daugherty Frank Joseph | officer: Chief Medical Officer | 90,121 | P-Purchase | A | 1,000 | 16.25 USD | 16,250 USD |
| Thursday, April 21st, 2022 | Patel Snehal | officer: CEO and CFO | 1,216,929 | P-Purchase | A | 6,000 | 16.09 USD | 96,540 USD |
| Tuesday, April 19th, 2022 | Patel Snehal | officer: CEO and CFO | 1,210,929 | P-Purchase | A | 6,000 | 16.74 USD | 100,440 USD |
| Tuesday, April 19th, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 255,995 | P-Purchase | A | 500 | 16.74 USD | 8,370 USD |
| Friday, February 11th, 2022 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 1,204,929 | P-Purchase | A | 5,500 | 19.80 USD | 108,900 USD |
| Friday, February 4th, 2022 | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 1,199,429 | P-Purchase | A | 5,000 | 19.59 USD | 97,950 USD |
| Monday, January 31st, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 255,495 | P-Purchase | A | 500 | 18.47 USD | 9,235 USD |
| Friday, January 21st, 2022 | Thompson Jaye | officer: VP Clinical Reg Affairs | 254,995 | P-Purchase | A | 500 | 16.33 USD | 8,165 USD |
